Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041439
Filing Date
2017-06-22
Accepted
2017-06-22 17:05:11
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
  Complete submission text file 0001209191-17-041439.txt   5466
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADAMAS PHARMACEUTICALS INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address
Rhodes Jennifer J (Reporting) CIK: 0001568249 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17925743